Covered recipient · General Payments record
MARC Y WASSERMAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$15,643.47
- Reported across 561 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,007.74 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $324.72 | 12 |
| Lilly USA, LLC | $237.81 | 6 |
| SK Life Science, Inc. | $89.75 | 3 |
| Averitas Pharma Inc. | $78.47 | 3 |
| PFIZER INC. | $78.14 | 4 |
| Vanda Pharmaceuticals Inc. | $61.94 | 2 |
| UCB, Inc. | $41.19 | 1 |
| Neurocrine BioSciences, Inc. | $30.95 | 1 |
| Lundbeck LLC | $29.37 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.40 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.94 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311733 | CMS |
| ABBVIE INC. | $27.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311735 | CMS |
| ABBVIE INC. | $33.12 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311737 | CMS |
| ABBVIE INC. | $29.61 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311739 | CMS |
| ABBVIE INC. | $34.41 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311741 | CMS |
| ABBVIE INC. | $20.25 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311743 | CMS |
| ABBVIE INC. | $32.66 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311745 | CMS |
| ABBVIE INC. | $31.87 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311747 | CMS |
| ABBVIE INC. | $19.39 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311749 | CMS |
| ABBVIE INC. | $30.86 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311751 | CMS |
| ABBVIE INC. | $25.35 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311753 | CMS |
| ABBVIE INC. | $16.10 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311755 | CMS |
| Averitas Pharma Inc. | $23.17 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133450538 | CMS |
| Averitas Pharma Inc. | $18.95 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133450542 | CMS |
| Averitas Pharma Inc. | $36.35 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133450546 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.00 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014115 | CMS |
| Lilly USA, LLC | $23.53 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135165099 | CMS |
| Lilly USA, LLC | $26.66 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135163939 | CMS |
| Lilly USA, LLC | $26.74 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148672 | CMS |
| Lilly USA, LLC | $18.16 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135156723 | CMS |
| Lilly USA, LLC | $21.83 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135150822 | CMS |
| Lilly USA, LLC | $120.89 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164711 | CMS |
| Lundbeck LLC | $29.37 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145979947 | CMS |
| Neurocrine Biosciences, Inc. | $30.95 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150824412 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.40 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119002637 | CMS |
| PFIZER INC. | $18.62 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131563994 | CMS |
| PFIZER INC. | $17.59 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131787571 | CMS |
| PFIZER INC. | $17.78 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131849865 | CMS |
| PFIZER INC. | $24.15 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131162663 | CMS |
| SK Life Science, Inc. | $26.27 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130555 | CMS |
| SK Life Science, Inc. | $29.45 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130567 | CMS |
| SK Life Science, Inc. | $34.03 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130605 | CMS |
| UCB, Inc. | $41.19 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143065843 | CMS |
| Vanda Pharmaceuticals Inc. | $31.97 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133926137 | CMS |
| Vanda Pharmaceuticals Inc. | $29.97 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133926139 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.